Marshall Wace North America’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-104,989
Closed -$1.72M – 1173
2020
Q2
$1.72M Buy
+104,989
New +$1.6M 0.01% 626
2020
Q1
– Sell
-20,790
Closed -$442K – 1186
2019
Q4
$442K Buy
+20,790
New +$461K ﹤0.01% 848
2019
Q2
– Sell
-13,793
Closed -$179K – 1108
2019
Q1
$179K Buy
+13,793
New +$241K ﹤0.01% 1010
2017
Q4
– Sell
-8,189
Closed -$688K – 1342
2017
Q3
$688K Buy
+8,189
New +$581K ﹤0.01% 1018
2017
Q2
– Sell
-215,364
Closed -$15.7M – 1272
2017
Q1
$15.7M Buy
+215,364
New +$14.1M 0.12% 202

Other funds holding ADNT

Marshall Wace North America's ADNT Position: Q3 2020 in Review

Marshall Wace North America sold out of Adient (ADNT) in Q3 2020, closing a stake of 104,989 shares — an estimated $1.72M sold.

Marshall Wace North America first reported a position in ADNT in Q1 2017 and held it in 5 quarters. The position peaked at $15.7M in Q1 2017. 272 funds tracked by Wall St. Rank hold ADNT as of Q3 2020.

  • Marshall Wace North America reported no remaining Adient position as of Q3 2020 after selling out during the quarter.
  • Marshall Wace North America sold 104,989 Adient shares in Q3 2020, an estimated $1.72M.
  • Marshall Wace North America first reported a position in Adient in Q1 2017 and held it in 5 quarters.
  • Marshall Wace North America's Adient position peaked at $15.7M in Q1 2017.
  • 272 funds tracked by Wall St. Rank held Adient as of Q3 2020.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.